ABT
ABBOTT LABORATORIES
NYSE · Healthcare · Medical - Devices · US
$102.55
+0.31%Next report
Analyst consensus
- Next report date
- Oct 21, 2026
- EPS estimate
- $1.43
- Revenue estimate
- $13.0B
Latest reported
- Last report date
- Jul 16, 2026
- EPS actual
- $1.31
- EPS estimate
- $1.28
- Revenue actual
- $12.6B
- Revenue estimate
- $12.5B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 7
- Avg surprise (4Q)
- +0.7%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $125
- PT range
- $112 – $135
- Analysts
- 11
11 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 16, 2026 | $1.28 | $1.31 | Beat 2.18% | $12.6B |
| Apr 16, 2026 | $1.14 | $1.15 | Beat 0.79% | $11.2B |
| Jan 22, 2026 | $1.50 | $1.50 | In line | $11.5B |
| Oct 15, 2025 | $1.30 | $1.30 | Miss -0.08% | $11.4B |
| Jul 17, 2025 | $1.26 | $1.26 | In line | $11.1B |
| Apr 16, 2025 | $1.07 | $1.09 | Beat 1.96% | $10.4B |
| Jan 22, 2025 | $1.34 | $1.34 | Beat 0.15% | $11.0B |
| Oct 16, 2024 | $1.20 | $1.21 | Beat 0.83% | $10.6B |
| Jul 18, 2024 | $1.10 | $1.14 | Beat 3.83% | $10.4B |
| Apr 17, 2024 | $0.95 | $0.98 | Beat 2.83% | $10.0B |
| Jan 24, 2024 | $1.18 | $1.19 | Beat 0.68% | $10.2B |
| Oct 18, 2023 | $1.09 | $1.14 | Beat 4.11% | $10.1B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 21, 2026